BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32056142)

  • 1. Pharmacological Prevention of Postoperative Recurrence in Crohn's Disease.
    Vuitton L; Peyrin-Biroulet L
    Drugs; 2020 Mar; 80(4):385-399. PubMed ID: 32056142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing postoperative recurrence in Crohn's disease: what does the future hold?
    Vuitton L; Koch S; Peyrin-Biroulet L
    Drugs; 2013 Nov; 73(16):1749-59. PubMed ID: 24132799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn's disease? Systematic review and meta-analysis.
    Uchino M; Ikeuchi H; Hata K; Minagawa T; Horio Y; Kuwahara R; Nakamura S; Watanabe K; Saruta M; Fujii T; Kobayashi T; Sugimoto K; Hirai F; Esaki M; Hiraoka S; Matsuoka K; Shinzaki S; Matsuura M; Inoue N; Nakase H; Watanabe M
    J Gastroenterol Hepatol; 2021 Apr; 36(4):864-872. PubMed ID: 33002235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
    Yamada A; Komaki Y; Patel N; Komaki F; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A
    Inflamm Bowel Dis; 2018 Feb; 24(3):502-509. PubMed ID: 29462385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a systematic review and network meta-analysis.
    Singh S; Garg SK; Pardi DS; Wang Z; Murad MH; Loftus EV
    Gastroenterology; 2015 Jan; 148(1):64-76.e2; quiz e14. PubMed ID: 25263803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.
    Carla-Moreau A; Paul S; Roblin X; Genin C; Peyrin-Biroulet L
    Dig Liver Dis; 2015 Mar; 47(3):191-6. PubMed ID: 25488057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor necrosis factor α is more effective than conventional medical therapy for the prevention of postoperative recurrence of Crohn's disease: a meta-analysis.
    Nguyen DL; Solaimani P; Nguyen ET; Jamal MM; Bechtold ML
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1152-9. PubMed ID: 25089549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery for Crohn's disease and anti-TNF agents: the changing scenario.
    Sorrentino D; Fogel S; Van den Bogaerde J
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):689-700. PubMed ID: 24161133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Prevention and Management of Postoperative Relapse in Pediatric Crohn's Disease.
    Yerushalmy-Feler A; Assa A
    Paediatr Drugs; 2019 Dec; 21(6):451-460. PubMed ID: 31628665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable outcomes of the consistent use versus switched use of anti- tumor necrosis factor agents in postoperative recurrent Crohn's disease following ileocolonic resection.
    Li Y; Stocchi L; Rui Y; Remzi FH; Shen B
    Int J Colorectal Dis; 2016 Nov; 31(11):1751-1758. PubMed ID: 27475090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of endoscopic monitoring in postoperative Crohn's disease patients already receiving pharmacological prevention of recurrence.
    González-Lama Y; Blázquez I; Suárez CJ; Oliva B; Matallana V; Calvo M; Vera I; Abreu L
    Rev Esp Enferm Dig; 2015 Oct; 107(10):586-90. PubMed ID: 26437976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Efficacy of Anti-TNF Therapies For The Prevention of Postoperative Recurrence of Crohn's Disease: A Systematic Review and Network Meta-Analysis of Prospective Trials.
    Bakouny Z; Yared F; El Rassy E; Jabbour R; Hallit R; Khoury N; Honein K; Bou Jaoude J
    J Clin Gastroenterol; 2019 Jul; 53(6):409-417. PubMed ID: 29517709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiopurines are associated with a reduction in surgical re-resections in patients with Crohn's disease: a long-term follow-up study in a regional and academic cohort.
    van Loo ES; Vosseberg NW; van der Heide F; Pierie JP; van der Linde K; Ploeg RJ; Dijkstra G; Nieuwenhuijs VB
    Inflamm Bowel Dis; 2013 Dec; 19(13):2801-8. PubMed ID: 24189041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of postoperative Crohn's disease.
    Yang Z; Wu Q; Wu K; Fan D
    Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):811-8. PubMed ID: 24809283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
    González-Lama Y; Suárez C; González-Partida I; Calvo M; Matallana V; de la Revilla J; Magaz M; Bernardo C; Agudo B; Ibarrola P; Relea L; Arévalo J; Vera MI; Abreu L
    J Crohns Colitis; 2016 Jan; 10(1):55-60. PubMed ID: 26520164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative Recurrence of Crohn's Disease: Pathophysiology, Diagnosis and Treatment.
    Di Sario A; Sassaroli P; Daretti L; Annulli G; Schiada L; Falcioni G; Bendia E; Antuono S; Benedetti A
    Curr Pharm Biotechnol; 2017; 18(12):979-988. PubMed ID: 29453848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologics for the prevention of postoperative Crohn's disease recurrence: A systematic review and meta-analysis.
    Zhao Y; Ma T; Chen YF; He XY; Ren LH; Chen J; Fang L; Su JW; Zhang HJ; Shi RH
    Clin Res Hepatol Gastroenterol; 2015 Oct; 39(5):637-49. PubMed ID: 25958300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.
    Allocca M; Landi R; Bonovas S; Fiorino G; Papa A; Spinelli A; Furfaro F; Peyrin-Biroulet L; Armuzzi A; Danese S
    Digestion; 2017; 96(3):166-172. PubMed ID: 28903094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease].
    Bor R; Farkas K; Bálint A; Szűcs M; Abrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
    Orv Hetil; 2013 Dec; 154(49):1943-8. PubMed ID: 24292112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of post-operative Crohn's disease in 2017: where do we go from here?
    Nguyen V; Kanth R; Gazo J; Sorrentino D
    Expert Rev Gastroenterol Hepatol; 2016 Nov; 10(11):1257-1269. PubMed ID: 27678049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.